Latest filing published 13 Mar 2018 for 9 METERS BIOPHARMA, INC..
Insider track record
No signal scores available.
David Lewis Olert: trading record in brief
All filings by David Lewis Olert on record concern 9 Meters Biopharma, Inc. In total, 5 filings cover trades dated from 7 July 2016 to 25 January 2018.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 13 March 2018 came the latest disclosure, a share grant in 9 Meters Biopharma, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 19 days. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to David Lewis Olert
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,000 shares0Common StockSEC:0001144204-18-014484:0
- 10,000 shares0Common StockSEC:0001209191-17-062216:0
- 10,000 shares0Common StockSEC:0001209191-17-045000:0
- 15,000 shares0Common StockSEC:0001209191-17-005632:0
- 25,000 shares0Common StockSEC:0001209191-16-134005:0
5 of 5 declarations